SG Americas Securities’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162M Buy
3,785,401
+2,854,246
+307% +$155M 0.09% 152
2026
Q1
$58.4M Buy
931,155
+544,637
+141% +$43.6M 0.06% 249
2025
Q4
$36.9M Sell
386,518
-19,225
-5% -$1.88M 0.05% 292
2025
Q3
$39.6M Buy
405,743
+290,455
+252% +$30.1M 0.13% 94
2025
Q2
$12.4M Sell
115,288
-274,605
-70% -$27.8M 0.05% 266
2025
Q1
$39.3M Buy
389,893
+161,198
+70% +$16.2M 0.13% 110
2024
Q4
$20.4M Buy
228,695
+196,961
+621% +$17.3M 0.08% 127
2024
Q3
$2.66M Sell
31,734
-198,927
-86% -$15.7M 0.01% 578
2024
Q2
$17.8M Buy
230,661
+15,725
+7% +$1.15M 0.1% 198
2024
Q1
$14.7M Buy
214,936
+142,642
+197% +$9.17M 0.07% 278
2023
Q4
$4.18M Buy
72,294
+36,787
+104% +$1.96M 0.04% 392
2023
Q3
$1.88M Sell
35,507
-120,010
-77% -$6.29M 0.02% 782
2023
Q2
$8.41M Sell
155,517
-309,036
-67% -$16.1M 0.06% 218
2023
Q1
$23.2M Buy
464,553
+436,458
+1,554% +$20.6M 0.27% 57
2022
Q4
$1.3M Sell
28,095
-45,445
-62% -$1.97M 0.02% 803
2022
Q3
$2.85M Buy
73,540
+34,199
+87% +$1.37M 0.04% 428
2022
Q2
$1.47M Sell
39,341
-3,747
-9% -$153K 0.02% 960
2022
Q1
$1.91M Sell
43,088
-104,376
-71% -$4.52M 0.01% 957
2021
Q4
$6.26M Buy
147,464
+22,788
+18% +$958K 0.03% 404
2021
Q3
$5.41M Buy
124,676
+14,173
+13% +$627K 0.03% 499
2021
Q2
$4.72M Buy
110,503
+5,194
+5% +$219K 0.02% 616
2021
Q1
$4.07M Buy
105,309
+6,084
+6% +$230K 0.02% 628
2020
Q4
$3.57M Buy
99,225
+14,127
+17% +$509K 0.02% 711
2020
Q3
$3.25M Sell
85,098
-9,564
-10% -$369K 0.02% 505
2020
Q2
$3.32M Buy
94,662
+2,519
+3% +$90.7K 0.03% 536
2020
Q1
$3.01M Buy
92,143
+75,110
+441% +$2.93M 0.03% 598
2019
Q4
$770K Sell
17,033
-43,073
-72% -$1.8M 0.01% 1454
2019
Q3
$2.45M Sell
60,106
-89,758
-60% -$3.8M 0.02% 827
2019
Q2
$6.44M Buy
149,864
+138,250
+1,190% +$5.32M 0.04% 420
2019
Q1
$446K Sell
11,614
-178,881
-94% -$6.83M ﹤0.01% 1935
2018
Q4
$6.73M Sell
190,495
-64,181
-25% -$2.33M 0.06% 300
2018
Q3
$9.8M Buy
254,676
+202,891
+392% +$7.09M 0.07% 273
2018
Q2
$1.69M Sell
51,785
-97,302
-65% -$2.93M 0.02% 1029
2018
Q1
$4.07M Sell
149,087
-315,282
-68% -$8.57M 0.03% 507
2017
Q4
$11.5M Buy
464,369
+402,142
+646% +$11.1M 0.11% 154
2017
Q3
$1.81M Sell
62,227
-66,003
-51% -$1.82M 0.02% 856
2017
Q2
$3.56M Sell
128,230
-100,451
-44% -$2.67M 0.03% 530
2017
Q1
$5.69M Buy
228,681
+28,489
+14% +$693K 0.05% 341
2016
Q4
$4.33M Buy
200,192
+140,249
+234% +$3.06M 0.04% 518
2016
Q3
$1.43M Sell
59,943
-28,263
-32% -$674K 0.02% 932
2016
Q2
$2.06M Buy
88,206
+24,101
+38% +$521K 0.01% 829
2016
Q1
$1.21M Buy
64,105
+25,149
+65% +$442K 0.01% 1197
2015
Q4
$718K Sell
38,956
-1,584
-4% -$28.4K 0.01% 1361
2015
Q3
$665K Sell
40,540
-70,837
-64% -$1.21M ﹤0.01% 981
2015
Q2
$1.97M Sell
111,377
-169,799
-60% -$3.03M 0.01% 727
2015
Q1
$4.99M Sell
281,176
-492,238
-64% -$7.78M 0.03% 405
2014
Q4
$10.2M Buy
773,414
+255,031
+49% +$3.26M 0.05% 384
2014
Q3
$6.12M Sell
518,383
-169,888
-25% -$2.14M 0.04% 440
2014
Q2
$8.79M Sell
688,271
-532,496
-44% -$6.92M 0.05% 372
2014
Q1
$16.5M Buy
1,220,767
+834,992
+216% +$11M 0.07% 305
2013
Q4
$4.64M Sell
385,775
-4,243,798
-92% -$50.1M 0.02% 676
2013
Q3
$54.4M Buy
4,629,573
+3,810,542
+465% +$41.2M 0.22% 88
2013
Q2
$7.59M Buy
+819,031
New +$6.95M 0.04% 454

Other funds holding BSX

SG Americas Securities's BSX Position: Q2 2026 in Review

SG Americas Securities increased its Boston Scientific (BSX) stake by 307% in Q2 2026, buying an estimated $155M and bringing the position to 3,785,401 shares worth $162M. The position accounts for 0.09% of the portfolio, ranked #152.

SG Americas Securities first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • SG Americas Securities held 3,785,401 shares of Boston Scientific worth $162M as of Q2 2026.
  • SG Americas Securities bought 2,854,246 Boston Scientific shares in Q2 2026, an estimated $155M.
  • Boston Scientific made up 0.09% of SG Americas Securities's portfolio in Q2 2026, its #152 holding.
  • SG Americas Securities first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.